JANUARY 21 - 29 2021

@BritSocGastro #BSGCampus

Confirmed Partners


Advanced Accelerator Applications (uk & Ireland) Ltd

Click here to

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine.

Boston Scientific

Click here to

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
To deliver high-quality patient care, you need a partner that provides innovative technologies, robust clinical and economic evidence, education, reimbursement support, and a portfolio of services. We are committed to working with you to provide support that makes a difference in the lives of your patients.


Click here to

Celltrion Healthcare is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US FDA cGMP and the EU GMP guidelines. Celltrion Healthcare endeavours to offer high-quality cost-effective solutions through an extensive global network that spans more than 120 different countries.


Click here to

We are Galapagos UK, a pioneering biotechnology company. Founded in Belgium in 1999 by our CEO Onno van de Stolpe, we now have over 1000 employees in 10 international locations including the UK, Belgium, the Netherlands, France, Germany, Italy and Spain. Our ambition is to become a leading biopharmaceutical company, focused on making a difference to the lives of people with inflammatory and fibrotic diseases. Galapagos has one of biotech’s largest pipelines of medicines with novel modes of action, and approximately 50% of our drug candidates are in clinical development. With our pioneering spirit, we aim to make a lasting, positive contribution to society by delivering the breakthrough medicines we have discovered to patients. We believe in ‘we’ not ‘us’ and together with the inflammation healthcare community, we will continue to push the possibilities of our work to tackle chronic disease and improve the lives of patients. Our motto is simple: We discover. We dare. We care.


Click here to

The Olympus Medical Systems Division offers a variety of products and system solutions for the healthcare sector, constantly seeking to improve diagnostic procedures and, consequently, the treatment of many diseases. Olympus is committed to developing new technologies, products, services and financial solutions that comply with the toughest industry standards and offer our customers improved safety, security, quality and productivity.


Click here to

Pfizer: Breakthroughs that change patients’ lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about our commitments, please visit us at www.pfizer.co.uk or follow us on Twitter (@Pfizer_UK), Facebook (@PfizerUK) and Instagram (@pfizeruk).

Date of preparation December 2020


Dr Falk Pharma Ltd

Click here to

Dr Falk Pharma UK
‘For us, every treatment is a journey’

Now in its 60th year Dr Falk is dedicated to providing treatments for digestive and metabolic diseases in a range of formulations, always with the aim of making treatment as convenient as possible.
Providing treatments for Inflammatory Bowel Disease, Eosinophilic Oesophagitis and Autoimmune Liver Diseases, our main focus is to improve patient outcomes.
We encourage debate and exchange between clinicians and researchers through our international and UK based meetings, providing a wealth of educational resources for HCPs and patients along with collaboration with relevant patient charities and organisations.
Now in their fourteenth year, Dr Falk / Guts UK (formerly Core) Awards provide recognition and financial support to Specialist Registrars, young doctors and medical students working in research in the field of gastroenterology and hepatology, along with nurses and dietitians who have delivered exemplary service to their patients.
Visit us or take a look at our website on www.drfalk.co.uk

Together we do more
Together we know more

Intercept Pharma UK & Ireland Ltd

Click here to

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.


Click here to

PENTAX Medical provides the most advanced clinically relevant endo-imaging solutions. Together with comprehensive customer service offerings, PENTAX Medical collaborates with customers to create long-term partnerships.

Tillotts Pharma Uk Ltd

Click here to

Tillotts are specialists in gastrointestinal health (GI) with over 30 years’ experience developing and manufacturing treatments for inflammatory bowel disease. Tillotts were the originators of the first modified-release mesalazine and now have over 2 million patient-years’ experience in the treatment of ulcerative colitis. With a development pipeline of new and innovative medicines for patients with diseases of the digestive system, Tillotts are passionate about GI.

Tillotts are also passionate about supporting health care professionals who care for GI patients in order to help improve patient care. Tillotts LOGIC Education programme offers training and support, and our annual Richard Driscoll Award encourages best practice sharing and recognises the achievements of IBD nurses.

Tillotts are proud to support and sponsor the IBD Registry and Crohn’s & Colitis UK.

Tillotts are part of the Zeria Group.



Click here to

Aquilant is proud to be Fujifilm’s Endoscopy partner in the UK.

Achieving optimal diagnostic and therapeutic results in endoscopic procedures is highly dependent on image quality. As the world’s largest imaging company, Fujifilm’s long-standing experience in medical imaging has allowed their engineers to develop Multi Light™ technology, fulfilling the need for improved visualisation in endoscopy – today and in the future.


This new high-performance illumination system is the latest innovation in Fujifilm’s medical device portfolio, and ensures that the quality of imaging meets the highest standards in brightness and contrast providing the innovative observation modes LCI and BLI. Specifically designed for the new illumination system, the ELUXEO™ 700 series of endoscopes featuring Multi Zoom and Freeze function allow for greater differentiation and provide detailed high-resolution imaging for both diagnosis and pre-therapeutic assessment.

With the unique CMOS chip built directly into the tip of the scope, the signal is digitally transmitted through the device, thus providing outstanding high-resolution imaging. All 760 endoscopes are equipped with CMOS.


Compatible with Fujifilm’s ELUXEO™ endoscopy series, CAD EYE has been designed utilising AI deep learning technology to support endoscopic lesion detection and characterisation in the colon.

CAD EYE has been developed at Fujifilm’s global AI technology centre in Tokyo, utilising an immense number of clinical images using Fujifilm endoscopy systems. As a result, CADEYE is a customised detection and characterisation supports real-time detection of polyps with White Light Imaging (WLI) and Linked Colour Imaging (LCI) and is aimed to improve the adenoma detection rate to expert level.


Click here to

Janssen-Cilag Ltd

Click here to

About the Janssen Pharmaceutical Companies of Johnson & Johnson

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.

Learn more at www.janssen.com/uk . Follow us at www.twitter.com/JanssenUK. Janssen-Cilag Limited is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.


Date of preparation: January 2021




Click here to

Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems. In the field of biosimilars, we develop products with a focus on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.

Surgical Science

Click here to

Surgical Science Sweden AB is a leading supplier of virtual reality simulators for evidence-based keyhole surgery training as well as endoscopy training, allowing novice surgeons and medical doctors to improve their psychomotor skills and instrument handling before entering the operation room. EndoSim allows trainees to practice both upper and lower GI endoscopy without the need to access patients, and ideal for allowing trainees to gain the necessary skills, particularly those at an early stage in their training, before having to undertake endoscopy in patients.



Click here to

BIOHIT HealthCare Ltd is synonymous with innovation, an essential requirement that enables providers to transform patient care, deliver value to payers and bring efficiency to users. BIOHIT’s diagnostic and monitoring tests do just that – in clinics, endoscopy units, laboratories, and in the home. Our class-leading range covers disease areas including dyspepsia and acid dysregulation, referral stratification, endoscopic biopsy testing, IBD and therapeutic drug monitoring, gut microbiota analysis, functional GI disease tests, CRC screening and more.

Erbe Medical Uk

Click here to

Ileostomy & Internal Pouch Association

Click here to









Key Features


40+ hours of live and on-demand webinar sessions focusing
on the key areas of gastroenterology


A electronic poster gallery featuring 445+ posters which
will inspire you with new initiatives and research


A unique platform that connects you with your colleagues,
peers, and industry experts

Discover the programme

Read our extensive programme
and discover who is speaking.

Register for BSG Campus

Sign up for BSG Campus today and
start personalising your own agenda.